Explore the latest in venous thromboembolism, including the latest in risk prediction and management with newer oral anticoagulants.
This randomized clinical trial assesses the efficacy and safety of rivaroxaban as postoperative thromboprophylaxis in patients undergoing bariatric surgery.
This cohort study investigated the association between treatment of dermatomyositis with intravenous immunoglobulin and thromboembolic events.
This Medical News article discusses the discovery of a mechanism that may protect against venous blood clots during long periods of immobility.
This Viewpoint discusses the growth of diagnostic stewardship beyond infectious disease to reduce diagnostic errors in other fields.
This JAMA Oncology Patient Page explains the risk, diagnosis, treatment, and prevention of thrombosis in patients with cancer.
This case report describes a diagnosis of Paget-Schroetter syndrome in a man in his 50s with a network of small veins in the left infraclavicular region discovered after unsuccessful left subclavian vein puncture.
This cohort study uses data from Medicare fee-for-service and a commercial insurance database to evaluate prescribing patterns of oral anticoagulants for patients with venous thromboembolism and identify clinical events that precede treatment changes.
This cohort study assesses whether active surveillance follow-up by physicians who implant retrievable inferior vena cava filters is associated with increased rates of device retrieval.
This cohort study examines the risk of venous thromboembolism in patients with COVID-19 who are not hospitalized.
This quality improvement study identifies adverse events for inferior vena cava filters and reports changes in adverse event reporting and estimated insertions between 2016 and 2020 in the US.
This prognostic study assesses the ONKOTEV score as a novel risk assessment model to evaluate the risk of venous thromboembolism (VTE) among outpatients with cancer.
This study assesses the association of sex chromosome aneuploidies with incidence of venous thromboembolism (VTE) in 2 large biobank populations.
This JAMA Patient Page describes pulmonary embolism signs and symptoms, risk factors, diagnosis, and treatment options.
This cohort study evaluates the safety and success of excimer laser sheath–assisted retrieval of embedded inferior vena cava filters.
This cohort study examines the association between time to surgery after COVID-19 diagnosis and the risk of a composite of major postoperative cardiovascular morbidity events within 30 days of surgery.
This randomized clinical trial investigates the effects of conventional catheter-directed thrombolysis plus anticoagulation in patients with acute intermediate-high risk of pulmonary embolism.
This cohort study assesses the rate of recurrence of venous thromboembolism (VTE) in patients with COVID-19–associated VTE who discontinued anticoagulation therapy.
This cohort study examines factors associated with hospital-associated venous thromboembolism and its incidence among hospitalized patients.
Customize your JAMA Network experience by selecting one or more topics from the list below.